Cannabis Biz Times

We tell important stories about cannabis cultivators and report happenings from around the industry.

[Cannabis Biz Times @CBTmag]

One of the largest medical cannabis companies in Florida closed its two cultivation and processing facilities and laid off 211 workers this month in the Tampa Bay area. More than 300,000 square feet of greenhouse space has exited the market.

https://t.co/cag7UG7tY4

[Cannabis Biz Times @CBTmag]

The Cannabist Co. is shutting down two more cannabis cultivation and manufacturing facilities in South Jersey, eliminating 86 jobs in the sector on Oct. 11 as part of its longstanding "severe liquidity crisis."

https://t.co/lQMJGOcVvZ

[Cannabis Biz Times @CBTmag]

The clock remains ticking for intoxicating hemp products in the U.S., but a pair of bipartisan House lawmakers threw the industry a lifeline through a bill to regulate and tax. But not all industry groups agree on its impact on synthetic cannabinoids.

https://t.co/5AHl59sQ3l

[Cannabis Biz Times @CBTmag]

Two U.S. senators introduced legislation that would provide a safe harbor for insurance companies seeking to serve state-sanctioned cannabis businesses.

"Cannabis businesses should have the same access to insurance coverage as any other business."

https://t.co/OrVokAtjD6

[Cannabis Biz Times @CBTmag]

A Massachusetts voter hoping to prevent a cannabis repeal question from appearing on the 2026 ballot failed to meet his burden of proof, the State Ballot Law Commission ruled.

"It's official: Big Marijuana's fate is on the ballot in Massachusetts."

https://t.co/nHehTL32jy

[Cannabis Biz Times @CBTmag]

U.S. Acting Attorney General Todd Blanche, when asked if he supports the proposed Schedule III cannabis rule and reducing cannabis possession penalties, said, "I will give the matter careful consideration."

https://t.co/tOSGYnpIPy

[Cannabis Biz Times @CBTmag]

A drug screening group and pharmaceutical company that are asking a federal court to stay the Trump DOJ's Schedule III medical cannabis order claimed that the DOJ has no defense other than "meritless" diversions and "speculative quibbles."

https://t.co/sg48DtGGJ5

[Cannabis Biz Times @CBTmag]

17 U.S. senators are backing legislation to federally decriminalize, regulate and tax cannabis, removing it entirely from the Controlled Substances Act.

"The only reefer madness I’m seeing is the continued federal prohibition of cannabis."

https://t.co/1qEWl1AFDk

[Cannabis Biz Times @CBTmag]

Nanticoke Gardens, one of New York's first licensed cannabis cultivators, weathered shifting regulations, unexpected costs and customer questions to create a year-round revenue stream for its 53-year-old garden center. Here's how ...

https://t.co/f1NuxtMiLY

[Cannabis Biz Times @CBTmag]

Idaho's medical cannabis legalization petition comes up 12,701 signatures short of a 2026 ballot position as organizers review "the state’s findings and our legal options."

“It appears that our confidence was misplaced.”

https://t.co/Tw1NR6sXHL

[Cannabis Biz Times @CBTmag]

Khalifa Kush is entering its sixth international market full steam ahead, while other cannabis brands backed by celebrities have fallen by the wayside. So, what’s allowed the brand to continue its hot streak? CEO DJ Saul has the answers.

https://t.co/KWun4sSXJ3

[Cannabis Biz Times @CBTmag]

Massachusetts voters will have the opportunity to repeal their state’s adult-use cannabis laws this November unless a new challenge prevails.

"We are not overly concerned. It’s the last desperate attempt to kill the question.”

https://t.co/Kzmfe0t08s

[Cannabis Biz Times @CBTmag]

Wyoming's attorney general finalized his decision to reject aligning the state's cannabis policies with the Trump administration's Schedule III order because that would be "inconsistent with the police powers exercised to date by the Wyoming Legislature."

https://t.co/ci15XAa0mj

[Cannabis Biz Times @CBTmag]

The DOJ says that anti-rescheduling groups attempting to stay the Trump admin.'s Schedule III cannabis order have "pocketbook interests" in prohibition that don't "systemically align" with the American public.

https://t.co/G6jutX8f7D

[Cannabis Biz Times @CBTmag]

Idaho activists hoping to legalize medical cannabis reached the final leg of a campaign to land a citizen-initiated statute on the 2026 ballot. "Now that the initiative is in the secretary of state’s hands, we are focused on seeing that process through."

https://t.co/Mpx1PPhezh

[Cannabis Biz Times @CBTmag]

Cannabis prohibitionists are doing their best to tear apart the HHS/FDA's scientific and medical evaluation and discredit the DEA's witnesses during the rescheduling hearing, but will they prevail in their argument that the plant has no medical use?

https://t.co/ZzjUQ6ToEG

[Cannabis Biz Times @CBTmag]

Lots happened on Day 1 of the DEA's cannabis rescheduling hearing, and Cannabis Business Times was the lone media in attendance for the testimony of the government's first witness. Here's the breakdown from inside the courtroom:

https://t.co/C8qqXsXv46

[Cannabis Biz Times @CBTmag]

Cannabis remains the most widely used drug worldwide, according to a new UN report, but youth perception of its harmfulness is increasing, and youth access is decreasing. Also, high-potency cannabis from North America has become increasingly sought-after.

https://t.co/3ykU2VroK6

[Cannabis Biz Times @CBTmag]

The DEA's key expert witness proposed for the cannabis rescheduling hearing plans to testify primarily on matters regarding medical cannabis (which is already placed in Schedule III), despite the judge's order forbidding testimony on that matter.

https://t.co/ilf0BbeWby

[Cannabis Biz Times @CBTmag]

8 U.S. House members filed the SAFE Banking Act of 2026, making it a bicameral approach to cannabis industry reform this Congress. “Forcing businesses to operate in cash not only hinders economic growth, but it also opens the doors for illegal activity.

https://t.co/4y59r8VBqY